0226 ECP Immune-Onc
BioCentury & Getty Images

Emerging Company Profile 

Immune-Onc building broad pipeline of myeloid checkpoint inhibitors

Emerging Company Profile: Founded by Guo-Liang Yu and Charlene Liao, the cancer play’s lead is a first-in-class ILT3 inhibitor  

Founded by serial entrepreneur Guo-Liang Yu and Genentech alum Charlene Liao, Immune-Onc is building a pipeline of myeloid-targeting cancer agents, starting with a first-in-class ILT3 inhibitor. 

Feb 26, 2021 | 11:12 PM GMT

Launched in 2016, Immune-Onc is part of a growing class of immuno-oncology companies

Read the full 784 word article

How to gain access

Continue reading with a
two-week free trial.